Kerim Babaoglu

3.1k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Kerim Babaoglu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kerim Babaoglu has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Kerim Babaoglu's work include Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (6 papers) and Computational Drug Discovery Methods (5 papers). Kerim Babaoglu is often cited by papers focused on Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (6 papers) and Computational Drug Discovery Methods (5 papers). Kerim Babaoglu collaborates with scholars based in United States, Italy and United Kingdom. Kerim Babaoglu's co-authors include Richard Lee, Stephen W. White, Jianjun Qi, Brian K. Shoichet, Kirk E. Hevener, Wei Zhao, David M. Ball, James Inglese, Brian Y. Feng and Ajit Jadhav and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Kerim Babaoglu

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase

2009 459 citations Kirk E. Hevener, Wei Zhao et al. Journal of Chemical Information and Modeling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerim Babaoglu United States	19	1.0k	478	454	412	208	20	1.8k
Nunzio Iraci Italy	32	782 0.8×	202 0.4×	742 1.6×	526 1.3×	387 1.9×	67	2.0k
Emanuele Perola United States	22	1.3k 1.3×	993 2.1×	455 1.0×	354 0.9×	82 0.4×	33	2.2k
Sandra Gemma Italy	35	1.4k 1.4×	656 1.4×	1.3k 2.9×	296 0.7×	123 0.6×	132	3.4k
Giosuè Costa Italy	30	1.4k 1.4×	220 0.5×	388 0.9×	433 1.1×	216 1.0×	107	2.5k
Simona Distinto Italy	30	1.5k 1.5×	668 1.4×	1.1k 2.4×	440 1.1×	221 1.1×	83	2.7k
Kenichi Akaji Japan	32	2.2k 2.2×	389 0.8×	1.3k 2.8×	506 1.2×	166 0.8×	188	3.4k
Shu-Qun Liu China	20	1.3k 1.2×	361 0.8×	228 0.5×	203 0.5×	121 0.6×	64	2.0k
Kevin J. Saliba Australia	32	1.2k 1.2×	408 0.9×	302 0.7×	405 1.0×	93 0.4×	77	3.6k
Maria Letizia Barreca Italy	35	1.3k 1.3×	335 0.7×	1.6k 3.6×	1.2k 2.9×	810 3.9×	113	3.5k
Pedro A. Valiente Cuba	16	1.3k 1.3×	541 1.1×	406 0.9×	225 0.5×	31 0.1×	47	2.4k

Countries citing papers authored by Kerim Babaoglu

Since Specialization

Citations

This map shows the geographic impact of Kerim Babaoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerim Babaoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerim Babaoglu more than expected).

Fields of papers citing papers by Kerim Babaoglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerim Babaoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerim Babaoglu. The network helps show where Kerim Babaoglu may publish in the future.

Co-authorship network of co-authors of Kerim Babaoglu

This figure shows the co-authorship network connecting the top 25 collaborators of Kerim Babaoglu. A scholar is included among the top collaborators of Kerim Babaoglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerim Babaoglu. Kerim Babaoglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Xiao, Aimin Tang, Kara S. Cox, et al.. (2019). Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes. mAbs. 11(8). 1415–1427. 23 indexed citations

Fradera, Xavier & Kerim Babaoglu. (2017). Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening. PubMed. 9(3). 196–212. 42 indexed citations

Ford, Melissa Coates & Kerim Babaoglu. (2017). Examining the Feasibility of Using Free Energy Perturbation (FEP+) in Predicting Protein Stability. Journal of Chemical Information and Modeling. 57(6). 1276–1285. 25 indexed citations

Yin, Jie, Kerim Babaoglu, Chad A. Brautigam, et al.. (2016). Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. Nature Structural & Molecular Biology. 23(4). 293–299. 111 indexed citations

Pokrovskii, Maria, Philip Morganelli, Eda Canales, et al.. (2013). A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity. Antimicrobial Agents and Chemotherapy. 58(1). 386–396. 18 indexed citations

Tsiang, Manuel, G.S. Jones, Anita Niedziela‐Majka, et al.. (2012). New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action. Journal of Biological Chemistry. 287(25). 21189–21203. 129 indexed citations

Kulkarni, Rima, Kerim Babaoglu, E.B. Lansdon, et al.. (2011). The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 47–54. 69 indexed citations

Eidam, O., Chiara Romagnoli, Emilia Caselli, et al.. (2010). Design, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase Inhibitors. Journal of Medicinal Chemistry. 53(21). 7852–7863. 56 indexed citations

Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2009). Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex. Journal of Biological Chemistry. 284(48). 33580–33599. 40 indexed citations

10.

Hevener, Kirk E., Jianjun Qi, Iain D. Kerr, et al.. (2009). Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase. Journal of Medicinal Chemistry. 53(1). 166–177. 75 indexed citations

11.

Teotico, Denise G., Kerim Babaoglu, Sugyan M. Dixit, et al.. (2009). Docking for fragment inhibitors of AmpC β-lactamase. Proceedings of the National Academy of Sciences. 106(18). 7455–7460. 78 indexed citations

12.

Hevener, Kirk E., Wei Zhao, David M. Ball, et al.. (2009). Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase. Journal of Chemical Information and Modeling. 49(2). 444–460. 459 indexed citations breakdown →

13.

Babaoglu, Kerim, Anton Simeonov, John J. Irwin, et al.. (2008). Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase. Journal of Medicinal Chemistry. 51(8). 2502–2511. 130 indexed citations

14.

He, Xiaoping, Robert C.A.M. van Waardenburg, Kerim Babaoglu, et al.. (2007). Mutation of a Conserved Active Site Residue Converts Tyrosyl-DNA Phosphodiesterase I into a DNA Topoisomerase I-dependent Poison. Journal of Molecular Biology. 372(4). 1070–1081. 34 indexed citations

15.

Babaoglu, Kerim, et al.. (2007). O-Aryloxycarbonyl Hydroxamates: New β-Lactamase Inhibitors That Cross-Link the Active Site. Journal of the American Chemical Society. 129(31). 9548–9549. 30 indexed citations

16.

Feng, Brian Y., Anton Simeonov, Ajit Jadhav, et al.. (2007). A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library. Journal of Medicinal Chemistry. 50(10). 2385–2390. 277 indexed citations

17.

Babaoglu, Kerim, Jianjun Qi, Richard Lee, & Stephen W. White. (2004). Crystal Structure of 7,8-Dihydropteroate Synthase from Bacillus anthracis. Structure. 12(9). 1705–1717. 69 indexed citations

18.

Babaoglu, Kerim, et al.. (2003). Novel Inhibitors of an Emerging Target in Mycobacterium tuberculosis; Substituted Thiazolidinones as Inhibitors of dTDP‐Rhamnose Synthesis.. ChemInform. 34(51). 2 indexed citations

19.

Babaoglu, Kerim, et al.. (2003). Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis. Bioorganic & Medicinal Chemistry Letters. 13(19). 3227–3230. 150 indexed citations

20.

Luo, Jiali, et al.. (2000). Novel Kinetics of Mammalian Glutathione Synthetase: Characterization of γ-Glutamyl Substrate Cooperative Binding. Biochemical and Biophysical Research Communications. 275(2). 577–581. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact